INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 45h ago
HOUSE PTR5h ago
SEC 13F5h ago
ROBINHOOD CHAIN5h ago
SEC FORM 4/Open-market saleVerified data

Purdue David Ryan sold ABBV

SVP, Controller · AbbVie Inc. · Common Stock, $0.01 par value

Side
SELL
Value
$1.22M
Shares
5,230
Price
$233.56
Executed
Mar 4, 2026
Disclosed
Mar 6, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Mar 4 executedMar 6, 2026 disclosed

ABBV · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
42/ 100 · ELEVATED
Methodology →
  • Transaction type+12 / 20

    Open-market sale

  • Relative size+22 / 25

    $1.2M reported value · 66.3% of prior position

  • Filing timing0 / 15

    Disclosed 2 business days after execution (deadline: 2)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · ABBV

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    13
    QE
    Quaggin Susan EDirector
    ABBVAbbVie Inc.
    Grant or award
    		A$15K
    59 sh
    		Sep 30, 2026Oct 2, 2026
    traded Sep 30, 2026
    		+2dSEC FORM 4

    Evidence

    24
    Pete SessionsRSelf
    ABBVAbbVie Inc.
    Sale
    		SELL$15K – $50KSep 14, 2026Sep 18, 2026
    traded Sep 14, 2026
    		+4dHOUSE PTR

    Evidence

    20
    Josh GottheimerDJoint
    ABBVAbbVie Inc.
    Sale
    		SELL$1,001 – $15KMay 5, 2026Jun 3, 2026
    traded May 5, 2026
    		+29dHOUSE PTR

    Evidence

    17
    QE
    Quaggin Susan EDirector
    ABBVAbbVie Inc.
    Grant or award
    		A—
    1,118 sh
    		May 8, 2026May 12, 2026
    traded May 8, 2026
    		+4dSEC FORM 4

    Evidence

    17
    DL
    Davis Jennifer L.Director
    ABBVAbbVie Inc.
    Grant or award
    		A—
    1,118 sh
    		May 8, 2026May 12, 2026
    traded May 8, 2026
    		+4dSEC FORM 4

    Evidence

    29
    CD
    Crum Demetris DEVP, CHIEF HR OFFICER
    ABBVAbbVie Inc.
    Tax withholding
    		F$370K
    1,594 sh
    		Feb 27, 2026Mar 6, 2026
    traded Feb 27, 2026
    		+7dSEC FORM 4

    Evidence

    27
    PR
    Purdue David RyanSVP, Controller
    ABBVAbbVie Inc.
    Tax withholding
    		F$625K
    2,692 sh
    		Feb 27, 2026Mar 3, 2026
    traded Feb 27, 2026
    		+4dSEC FORM 4

    Evidence

    13
    PR
    Purdue David RyanSVP, Controller
    ABBVAbbVie Inc.
    Grant or award
    		A—
    890 sh
    		Feb 18, 2026Feb 20, 2026
    traded Feb 18, 2026
    		+2dSEC FORM 4

    Evidence

    13
    PR
    Purdue David RyanSVP, Controller
    ABBVAbbVie Inc.
    Grant or award
    		A—
    1,292 sh
    		Feb 18, 2026Feb 20, 2026
    traded Feb 18, 2026
    		+2dSEC FORM 4

    Evidence

    13
    PR
    Purdue David RyanSVP, Controller
    ABBVAbbVie Inc.
    Grant or award
    		A—
    1,384 sh
    		Feb 18, 2026Feb 20, 2026
    traded Feb 18, 2026
    		+2dSEC FORM 4

    Evidence

    9
    PR
    Purdue David RyanSVP, Controller
    ABBVAbbVie Inc.
    Grant or award
    		A—
    4,875 sh
    		Feb 18, 2026Feb 20, 2026
    traded Feb 18, 2026
    		+2dSEC FORM 4

    Evidence

    13
    TR
    Thakkar RoopalEVP, R&D and CSO
    ABBVAbbVie Inc.
    Grant or award
    		A—
    6,015 sh
    		Feb 18, 2026Feb 20, 2026
    traded Feb 18, 2026
    		+2dSEC FORM 4

    Evidence

    9
    TR
    Thakkar RoopalEVP, R&D and CSO
    ABBVAbbVie Inc.
    Grant or award
    		A—
    2,138 sh
    		Feb 18, 2026Feb 20, 2026
    traded Feb 18, 2026
    		+2dSEC FORM 4

    Evidence

    13
    TR
    Thakkar RoopalEVP, R&D and CSO
    ABBVAbbVie Inc.
    Grant or award
    		A—
    3,346 sh
    		Feb 18, 2026Feb 20, 2026
    traded Feb 18, 2026
    		+2dSEC FORM 4

    Evidence

    13
    TR
    Thakkar RoopalEVP, R&D and CSO
    ABBVAbbVie Inc.
    Grant or award
    		A—
    6,638 sh
    		Feb 18, 2026Feb 20, 2026
    traded Feb 18, 2026
    		+2dSEC FORM 4

    Evidence

    9
    TR
    Thakkar RoopalEVP, R&D and CSO
    ABBVAbbVie Inc.
    Grant or award
    		A—
    21.9K sh
    		Feb 18, 2026Feb 20, 2026
    traded Feb 18, 2026
    		+2dSEC FORM 4

    Evidence

    21
    SC
    Siatis Perry CEVP, GC AND SECRETARY
    ABBVAbbVie Inc.
    Grant or award
    		A—
    16.3K sh
    		Feb 18, 2026Feb 20, 2026
    traded Feb 18, 2026
    		+2dSEC FORM 4

    Evidence

    17
    SC
    Siatis Perry CEVP, GC AND SECRETARY
    ABBVAbbVie Inc.
    Grant or award
    		A—
    5,792 sh
    		Feb 18, 2026Feb 20, 2026
    traded Feb 18, 2026
    		+2dSEC FORM 4

    Evidence

    17
    SC
    Siatis Perry CEVP, GC AND SECRETARY
    ABBVAbbVie Inc.
    Grant or award
    		A—
    5,628 sh
    		Feb 18, 2026Feb 20, 2026
    traded Feb 18, 2026
    		+2dSEC FORM 4

    Evidence

    13
    SC
    Siatis Perry CEVP, GC AND SECRETARY
    ABBVAbbVie Inc.
    Grant or award
    		A—
    5,808 sh
    		Feb 18, 2026Feb 20, 2026
    traded Feb 18, 2026
    		+2dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0002057696-26-000008
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Mar 4, 2026
    Published
    Mar 6, 2026
    Ingested by INSIDER
    Nov 5, 04:13 UTC
    Last re-read
    Nov 5, 04:13 UTC

    Extracted facts

    Filer
    Purdue David Ryan
    Role
    SVP, Controller
    Transaction
    Open-market saleAs filed: “S”
    Asset
    AbbVie Inc.
    Ticker
    ABBV
    Shares
    5,230
    Price per share
    $233.56
    Value
    $1,221,519
    Execution date (reported)
    Mar 4, 2026
    Owned after transaction
    2,654 shares
    Days from execution to publication
    2

    Calculation

    Value = shares × reported price per share

    • Shares: 5,230
    • Price: $233.56

    = $1,221,519

    What this establishes

    Purdue David Ryan filed this Form 4 reporting a open-market sale of ABBV on Mar 4, 2026. It became public on Mar 6, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    SVP, Controller
    Purdue David Ryancik:0002057696
    Issuer
    AbbVie Inc.cik:0001551152

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.